Respiratory Syncytial Virus Prevention through Monoclonal Antibodies: A Cross-Sectional Study on Knowledge, Attitudes, and Practices of Italian Pediatricians

Respiratory Syncytial Virus (RSV) is a leading cause of morbidity and hospitalization in all infants. Many RSV vaccines and monoclonal antibodies (mAb) are currently under development to protect all infants, but to date preventive options are available only for preterms. In this study, we assessed t...

Full description

Bibliographic Details

Published in:	Pediatric Reports
Main Authors:	Matteo Riccò, Silvia Corrado, Milena Pia Cerviere, Silvia Ranzieri, Federico Marchesi
Format:	Article
Language:	English
Published:	MDPI AG 2023-02-01
Subjects:	RSV RSV all infants RSV epidemiology RSV pediatric burden RSV prevention RSV vaccines
Online Access:	https://www.mdpi.com/2036-7503/15/1/13